Eleonora Bongiovanni

7PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyClinical pharmacology and therapeuticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2026
Managing metastatic cutaneous squamous cell carcinoma in VEXAS syndrome: a therapeutic challenge.

Eleonora Bongiovanni, Umberto Santaniello, Chiara Astrua

|Nov 13, 2025
The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies.

Valentina Pala, Francois Rosset, Luca Mastorino

|Sep 22, 2025
Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence.

Francois Rosset, Nadia Sciamarrelli, Luca Mastorino

|Jul 23, 2025
Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years.

Luca Mastorino, Paolo Dapavo, Michela Ortoncelli

|Jun 11, 2025
Dose modulation strategies in patients with psoriasis: real-world comparison between secukinumab and brodalumab for up to 1 year after dose spacing.

Luca Mastorino, Paolo Dapavo, Michela Ortoncelli

|Mar 21, 2025
Safety Profile of Baricitinib in Patients With Severe Alopecia Areata: A Prospective Study.

Isotta Giunipero di Corteranzo, Eleonora Bongiovanni, Stephano Cedirian

Pageof 2